Distinct pharmacological and functional properties of NMDA receptors in mouse cortical astrocytes
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND PURPOSE Astrocytes of the mouse neocortex express functional NMDA receptors, which are not blocked by Mg 2+ ions. However, the pharmacological profile of glial NMDA receptors and their subunit composition is far from complete. EXPERIMENTAL APPROACH We tested the sensitivity of NMDA receptor‐mediated currents to the novel GluN2C/D subunit‐selective antagonist UBP141 in mouse cortical astrocytes and neurons. We also examined the effect of memantine, an antagonist that has substantially different affinities for GluN2A/B and GluN2C/d‐containing receptors in physiological concentrations of extracellular Mg 2+. KEY RESULTS UBP141 had a strong inhibitory action on NMDA receptor‐mediated transmembrane currents in the cortical layer II/III astrocytes with an IC 50 of 2.29 µM and a modest inhibitory action on NMDA‐responses in the pyramidal neurons with IC 50 of 19.8 µM. Astroglial and neuronal NMDA receptors exhibited different sensitivities to memantine with IC 50 values of 2.19 and 10.8 µM, respectively. Consistent with pharmacological differences between astroglial and neuronal NMDA receptors, NMDA receptors in astrocytes showed lower Ca 2+ permeability than neuronal receptors with PCa/PNa ratio of 3.4. CONCLUSIONS AND IMPLICATIONS The biophysical and pharmacological properties of the astrocytic NMDA receptors strongly suggest that they have a tri‐heteromeric structure composed of GluN1, GluN2C/D and GluN3 subunits. The substantial difference between astroglial and neuronal NMDA receptors in their sensitivity to UBP141 and memantine may enable selective modulation of astrocytic signalling that could be very helpful for elucidating the mechanisms of neuron‐glia communications. Our results may also provide the basis for the development of novel therapeutic agents specifically targeting glial signalling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90210-0 · Cited by 3,535 · cited 1×
“GluN2 and GluN3 subunit expression exhibits regional specificity and undergoes developmental regulation (Monyer et al., 1994; Cull-Candy and Leszkiewicz, 2004; Paoletti and Neyton, 2007; Henson et al., 2010).”
NMDA receptor subunits: function and pharmacology
PAOLETTI, P., & NEYTON, J. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.011 · Cited by 887
Endele, S., Rosenberger, G., Geider, K., Popp, B., Tamer, C., Stefanova, I., Milh, M., Kortüm, F., Fritsch, A., Pientka, F. K., et al. (2010) · Nature Genetics · doi:10.1038/ng.677 · Cited by 499 · cited 1×
“Recently, it has been reported that splicing of the GluN2A subunit can lead to loss of Mg2+ block (Endele et al., 2010).”
Iino, M., Ozawa, S., & Tsuzuki, K. (1990) · The Journal of Physiology · doi:10.1113/jphysiol.1990.sp018060 · Cited by 497 · cited 2×
“…neurons agrees with data reported previously for neu- British Journal of Pharmacology (2011) 163 1755–1766 1761 ronal NMDA receptors and various heterologously expressed GluN1/GluN2 subunit combinations (Mayer and Westbrook, 1987; Iino et al., 1990; Matsuda et al., 2003; Tong et al., 2008).”
alpha-Bungarotoxin-sensitive hippocampal nicotinic receptor channel has a high calcium permeability
Castro, N. G., & Albuquerque, E. X. (1995) · Biophysical Journal · doi:10.1016/s0006-3495(95)80213-4 · Cited by 273 · cited 4×
“2) receptors (Castro and Albuquerque, 1995; Evans et al., 1996; Fucile, 2004), and is larger than the permeability of Ca2+-permeable kainate (PCa/PNa=0.”
InfluentialMg2+Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine
Kotermanski, S. E., & Johnson, J. W. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3703-08.2009 · Cited by 271 · cited 6×
“It should be noted that the IC50 value for NMDA-evoked currents in neurons obtained in our experiments is in very good agreement with the data of Kotermanski and Johnson (2009) on the affinity of memantine to GluN2A and B subunits (constituent subunits of the majority of neuronal NMDA receptors) at…”
InfluentialBurzomato, V., Frugier, G., Pérez-Otaño, I., Kittler, J. T., & Attwell, D. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.195503 · Cited by 78 · cited 4×
“, 2002) and white matter oligodendrocytes have been shown to express tri-heteromeric receptors (Karadottir et al., 2005; Burzomato et al., 2010).”
Influential
Cited by
Verkhratsky, A., & Nedergaard, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00042.2016 · Cited by 1,678
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels
Hansen, K. B., Wollmuth, L. P., Bowie, D., Furukawa, H., Menniti, F. S., Sobolevsky, A. I., Swanson, G. T., Swanger, S. A., Greger, I. H., Nakagawa, T., et al. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000131 · Cited by 686
Glial cells in (patho)physiology
Parpura, V., Heneka, M. T., Montana, V., Oliet, S. H. R., Schousboe, A., Haydon, P. G., Stout, R. F., Spray, D. C., Reichenbach, A., Pannicke, T., et al. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07664.x · Cited by 561
“Astroglial NMDA receptors are characterized by weak Mg2+ block at )80 mV [the block develops at more negative membrane potentials (Palygin et al. 2011)] and moderate Ca2+ permeability [PCa/Pmonovalent 3; (Palygin et al. 2010)].”
BackgroundThe Role of NMDA Receptors in Alzheimer’s Disease
Liu, J., Chang, L., Song, Y., Li, H., & Wu, Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00043 · Cited by 535
“GluN3A and GluN3B subunits can co-assemble with GluN2 subunits to form triheteromeric GluN1/GluN2/GluN3 receptors that are involved in synapse maturation during brain development (Paoletti, 2011; Paoletti et al., 2013; Pérez-Otaño et al., 2016).”
BackgroundInfluentialGonzález-Reyes, R. E., Nava-Mesa, M. O., Vargas-Sánchez, K., Ariza-Salamanca, D., & Mora-Muñoz, L. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00427 · Cited by 527
Metadata
- Authors
- Palygin, O., Lalo, U., & Pankratov, Y.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2011-07-25
- Volume
- 163
- Issue
- 8
- Pages
- 1755-1766
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1516122596
- Cited by
- 119
- References
- 8
- FWCI
- 3.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Distinct pharmacological and functional properties of NMDA receptors in mouse cortical astrocytes. https://app.cochat.ai/papers/10.1111/j.1476-5381.2011.01374.x
- The paper
- Palygin, O., Lalo, U., & Pankratov, Y. (2011). Distinct pharmacological and functional properties of NMDA receptors in mouse cortical astrocytes. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2011.01374.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.